top of page
PatientsCure THERAPEUTICS
Patient Cure Therapeutics is a pharmaceutical company and we focus on developing treatment drugs from preclinical trials to commercialization.
​
We are currently developing Phase I AAV to deliver safe and effective gene replacement to the liver .This treatment produces sustained therapeutic protein expression for diseases like haemophilia B and fabry disease.
​
These clinical trials will better lives for people with inherited systemic debilitating disease .
Our focus is on developing treatments for diseases with high unmet needs followed by expansion to address diseases in neurology and inflammation.
​
bottom of page